0000899243-23-016396.txt : 20230623
0000899243-23-016396.hdr.sgml : 20230623
20230623172125
ACCESSION NUMBER: 0000899243-23-016396
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230622
FILED AS OF DATE: 20230623
DATE AS OF CHANGE: 20230623
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kender Richard N
CENTRAL INDEX KEY: 0001381205
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 231038748
MAIL ADDRESS:
STREET 1: C/O MERCK & CO., INC.
STREET 2: ONE MERCK DRIVE, WS2A-40
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-22
0
0001609809
Seres Therapeutics, Inc.
MCRB
0001381205
Kender Richard N
C/O SERES THERAPEUTICS, INC.
200 SIDNEY STREET
CAMBRIDGE
MA
02139
1
0
0
0
0
Stock Option (right to buy)
5.46
2023-06-22
4
A
0
35000
0.00
A
2033-06-21
Common Stock
35000
35000
D
The option vests in full on the earlier of June 22, 2024 or the day immediately prior to the company's 2024 annual meeting of shareholders.
/s/ Thomas J. DesRosier, Attorney-in-Fact
2023-06-23